Literature DB >> 11576910

Indinavir nephropathy revisited: a pattern of insidious renal failure with identifiable risk factors.

R F Reilly1, K Tray, M A Perazella.   

Abstract

Indinavir is a well-known cause of crystal-induced acute renal failure, dysuria and flank pain, and nephrolithiasis. Recently a more insidious tubulointerstitial lesion has been recognized as secondary to the drug. We report a case of a hepatitis C-positive patient on long-term indinavir therapy for human immunodeficiency virus (HIV) who developed a slowly progressive rise in serum creatinine. Renal biopsy revealed a diffuse interstitial infiltrate with numerous eosinophils and scarring. The tubules showed focal necrosis and dilation with elongated crystals present within their lumina. The elevated serum creatinine decreased to a new baseline over several months with the discontinuation of indinavir. We review the literature of renal syndromes associated with indinavir focusing on chronic progressive tubulointerstitial injury and speculate on risk factors and potential mechanisms of indinavir-induced renal injury.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11576910     DOI: 10.1053/ajkd.2001.27732

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  14 in total

Review 1.  Mechanisms of antimicrobial-induced nephrotoxicity in children.

Authors:  Kevin J Downes; Molly Hayes; Julie C Fitzgerald; Gwendolyn M Pais; Jiajun Liu; Nicole R Zane; Stuart L Goldstein; Marc H Scheetz; Athena F Zuppa
Journal:  J Antimicrob Chemother       Date:  2020-01-01       Impact factor: 5.790

Review 2.  HIV therapies and the kidney: some good, some not so good?

Authors:  Lene Ryom; Amanda Mocroft; Jens Lundgren
Journal:  Curr HIV/AIDS Rep       Date:  2012-06       Impact factor: 5.071

3.  Urological management of indinavir-associated acute renal failure in HIV-positive patients.

Authors:  C Kalaitzis; P Passadakis; S Giannakopoulos; S Panagoutsos; E Mpantis; A Triantafyllidis; S Touloupidis; V Vargemezis
Journal:  Int Urol Nephrol       Date:  2006-12-19       Impact factor: 2.370

Review 4.  Drug-Induced Kidney Stones and Crystalline Nephropathy: Pathophysiology, Prevention and Treatment.

Authors:  Michel Daudon; Vincent Frochot; Dominique Bazin; Paul Jungers
Journal:  Drugs       Date:  2018-02       Impact factor: 9.546

Review 5.  The nephrotoxic effects of HAART.

Authors:  Hassane Izzedine; Marianne Harris; Mark A Perazella
Journal:  Nat Rev Nephrol       Date:  2009-10       Impact factor: 28.314

6.  Treatment of indinavir sulfate induced urolithiasis in HIV-positive patients.

Authors:  Christos Kalaitzis; Georgios Dimitriadis; Triantafylos Tsatidis; Rainer Kuntz; Stavros Touloupidis; Georgios Kelidis
Journal:  Int Urol Nephrol       Date:  2002       Impact factor: 2.370

Review 7.  Drug-induced renal calculi: epidemiology, prevention and management.

Authors:  Michel Daudon; Paul Jungers
Journal:  Drugs       Date:  2004       Impact factor: 9.546

8.  [Indinavir urolithiasis in HIV-positive patients. Treatment and prophylaxis].

Authors:  C Kalaitzis; S Touloupidis; E Patris; K Lehrich; R M Kuntz
Journal:  Urologe A       Date:  2004-02       Impact factor: 0.639

9.  Suppression of HIV-1 replication by antiretroviral therapy improves renal function in persons with low CD4 cell counts and chronic kidney disease.

Authors:  Robert C Kalayjian; Nora Franceschini; Samir K Gupta; Lynda A Szczech; Ezekiel Mupere; Ronald J Bosch; Marlene Smurzynski; Jeffrey M Albert
Journal:  AIDS       Date:  2008-02-19       Impact factor: 4.177

Review 10.  Drug-Induced Acute Kidney Injury.

Authors:  Mark A Perazella; Mitchell H Rosner
Journal:  Clin J Am Soc Nephrol       Date:  2022-03-10       Impact factor: 10.614

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.